NEW DELHI: With the chances of a Covid-19 vaccine being available soon increasing, Prime Minister Narendra Modi said on Tuesday that mobile technology will be used for mass inoculation against the pandemic.
Speaking at the Mobile Congress of India, he said that mobile technology has enabled benefits worth billions of dollars to reach those who deserve it and also helped the poor and vulnerable during the pandemic.
“It is also with the help of mobile technology that we will embark on one of the largest Covid-19 vaccination campaigns in the world,” he said.
Coronavirus Outbreak: Live Updates
He did not provide details.
Three leading developers of coronavirus vaccines, Pfizer Inc and AstraZeneca Plc and Bharat Biotech, have applied for emergency use authorization in India.
While Pfizer India has applied to the drug regulator for permission to import its experimental mRNA vaccine for sale and distribution without the requirement for local clinical trials, Serum Institute of India Ltd, AstraZeneca’s vaccine partner in India, has applied for authorization. of emergency use using data from Phase-III trials that were conducted locally as well as in Brazil and the UK.
Hyderabad-based Bharat Biotech has sought out Covaxin, which is being developed indigenously in collaboration with the Indian Council for Medical Research (ICMR).
The apps mean a massive vaccination effort could be underway shortly in a nation that has the second-highest number of coronavirus cases in the world.
At the IMC, Modi said: “We need to work together to ensure a timely deployment of 5G to take a leap into the future and empower millions of Indians.”
He also proposed to make India a global center for telecommunications equipment, design, development and manufacturing.
Speaking about mobile technology, he said it was because of this that the government was able to bring billions of dollars worth of benefits to millions of Indians.
“It is thanks to mobile technology that we are seeing billions of cashless transactions driving formalization and transparency. It is thanks to mobile technology that we will enable a seamless contactless interface at toll booths,” he said.
Speaking at the Mobile Congress of India, he said that mobile technology has enabled benefits worth billions of dollars to reach those who deserve it and also helped the poor and vulnerable during the pandemic.
“It is also with the help of mobile technology that we will embark on one of the largest Covid-19 vaccination campaigns in the world,” he said.
Coronavirus Outbreak: Live Updates
He did not provide details.
Three leading developers of coronavirus vaccines, Pfizer Inc and AstraZeneca Plc and Bharat Biotech, have applied for emergency use authorization in India.
While Pfizer India has applied to the drug regulator for permission to import its experimental mRNA vaccine for sale and distribution without the requirement for local clinical trials, Serum Institute of India Ltd, AstraZeneca’s vaccine partner in India, has applied for authorization. of emergency use using data from Phase-III trials that were conducted locally as well as in Brazil and the UK.
Hyderabad-based Bharat Biotech has sought out Covaxin, which is being developed indigenously in collaboration with the Indian Council for Medical Research (ICMR).
The apps mean a massive vaccination effort could be underway shortly in a nation that has the second-highest number of coronavirus cases in the world.
At the IMC, Modi said: “We need to work together to ensure a timely deployment of 5G to take a leap into the future and empower millions of Indians.”
He also proposed to make India a global center for telecommunications equipment, design, development and manufacturing.
Speaking about mobile technology, he said it was because of this that the government was able to bring billions of dollars worth of benefits to millions of Indians.
“It is thanks to mobile technology that we are seeing billions of cashless transactions driving formalization and transparency. It is thanks to mobile technology that we will enable a seamless contactless interface at toll booths,” he said.
.
